Medical College of Wisconsin Cancer Center

01/28/2026

MILWAUKEE (CBS 58) -- Fifty years ago, the MACC Fund started on the floor of what is now the UW-Milwaukee Panther Arena. Now, there's a Panthers player helping spread cancer awareness with his own battle. "When

01/28/2026

Registration is now open for the 11th Annual Midwest Tumor Microenvironment (TME) Conference, May 18-20 at the Medical College of Wisconsin Cancer Center.

The conference brings together clinicians, researchers, students, and trainees from across the Midwest to share the latest advances in TME research and build cross-disciplinary collaborations. We’re honored to welcome Pepper Schedin, PhD, as our keynote speaker, along with nine faculty speakers and a Career Development Workshop.

Learn more and register: https://bit.ly/4pV4F5s

01/26/2026

Recently on 860AM WNOV The Voice’s Your Health and You, host Deb Nevels from our Community Outreach and Engagement team spoke with Denise Uyar, MD about one of the most preventable cancers, cervical cancer.

January is Cervical Cancer Awareness Month, and too many people are still being diagnosed late, often because they aren’t getting to the doctor or keeping up with recommended screenings.

Dr. Uyar reminds us that cervical cancer develops slowly and has a pre-cancer phase, which means there’s a long window to catch abnormal cells early through pap smears, HPV testing, and routine exams.

Listen to the full conversation:

YOUR HEALTH AND YOU WITH YOUR HOST DEB NEVELS / Cervical Cancer Awareness + Building the Next Generation

01/23/2026

On February 14, health ministry leaders from diverse faith communities will come together in shared commitment as Ambassadors for the Medical College of Wisconsin Cancer Center’s Ribbons of Faith health ministry initiative, led by the Department of Community Outreach and Engagement.

Through Ribbons of Faith, trusted leaders help promote health and wellness in their communities by coordinating activities like health fairs, educational events, and cancer screening efforts, working together to reduce the burden of cancer.

Ambassador gatherings are held on select Saturdays from 10 a.m.–12 p.m. at ThriveOn King and provide space for idea sharing, planning, and resource support throughout the year.

RSVP details in comments ⬇️

01/21/2026

More people are reaching the five-year milestone after a cancer diagnosis. That’s giving people more time to experience life’s special moments— grandchildren being born, graduations, weddings, and everything in between.

The new data from the American Cancer Society shows that for the first time ever, about 70% of people now live five years after their diagnosis, according to its annual report published in the organization’s medical journal.

Read the report: https://acsjournals.onlinelibrary.wiley.com/doi/10.3322/caac.70043

01/19/2026

An early-phase clinical trial is exploring a new approach to immunotherapy for hard-to-treat solid tumors.

Led by Deepak Kilari, MD, this study is evaluating TEV-56278, designed to strengthen the body’s own cancer-fighting immune cells, alone or in combination with pembrolizumab.

Because Medical College of Wisconsin Cancer Center is participating early, patients across Wisconsin may have access to this therapy before it’s available elsewhere.

Learn more: https://loom.ly/v242vU8

A first-in-human study is testing a targeted IL-2-based therapy designed to boost the body’s own cancer-fighting cells.

01/14/2026

Cervical cancer is largely preventable, but not in every case.

The Ojesina Lab investigates the interactions between genomic alterations and microbes to learn about less-common types of cervical cancers prevention can’t catch.

From studying what makes these cancers rare, to mentoring the next generation of scientists, this lab is closing gaps for patients whose disease cannot be prevented through vaccination alone.

01/12/2026

What if identifying cancer and deciding how to treat it could happen in the same step?

Theranostics makes this possible by uniting diagnosis and therapy around the same cancer-specific target, allowing clinicians to see how cancer behaves and act on that insight immediately. This cutting-edge approach is already bringing greater precision and confidence to cancer care at Medical College of Wisconsin Cancer Center.

Read more about the next wave of precision oncology: https://cancer.mcw.edu/stories/MCW-Takes-Cancer-Care-by-Storm-Theranostics-and-the-Next-Wave-of-Precision-Oncology

01/08/2026

The Vince Lombardi Cancer Foundation recently announced more than $300,000 in grant funding for cancer research and patient support programs across Wisconsin and nearby states.

Nikki Lytle, PhD, discussed how Lombardi funding led to an unexpected discovery in her pancreatic cancer work, uncovering how chemotherapy may affect immune cells in the liver and opening the door to new publications and national grants.

Listen to the conversation:

Ann Marie Moss from VLCF and Dr. Nikki Lytle from the Medical College of Wisconsin talk about how the Vince Lombardi Cancer Foundation recently awarded over ...

01/06/2026

THE AUDAXITY RIDE IS BACK
📅August 2 |📍American Family Field

Year one showed what’s possible.
Year two is about what’s necessary.

This year we aim to double the riders, double the energy, and double the impact for cancer research.

Join Us: https://audaxity.donordrive.com/index.cfm?fuseaction=register.start&eventID=505

01/02/2026

The widely used chemotherapy drug doxorubicin helps kill cells, but it can also damage heart cells and lead to heart disease.

Medical College of Wisconsin Cancer Center researcher Chun Liu, PhD, is studying what makes some heart cells vulnerable and how to protect them from this toxicity.

Learn how repressing a specific gene could help prevent chemotherapy-related heart damage and improve long-term outcomes: https://www.mcw.edu/mcwknowledge/mcw-stories/to-protect-the-heart-from-chemotherapy-researcher-looks-to-genes

12/29/2025

When Rusty Konkol’s melanoma continued to spread despite immunotherapy, he turned to Amy Harker-Murray, MD, for a new treatment option: lifileucel. It is the only FDA-approved tumor infiltrating lymphocyte (TIL) therapy for metastatic melanoma. Rusty became the first person in Wisconsin to receive this innovative treatment.

TIL therapy harnesses the body’s own immune system. Tumor-fighting white blood cells are removed, multiplied in a lab, and infused back into the body to strengthen the immune response.

Following treatment, Rusty’s scans show his tumors are shrinking. He’s back to doing the things he loves, hunting, fishing, and splitting wood.

Learn how clinical trials and research led to FDA approval, bringing this breakthrough cancer therapy to Wisconsin: https://www.froedtert.com/stories/treatment-advanced-melanoma